Department of Neurology (I.M.S., C.M., A.H.S., A.L.S.T., M.M.P., A.R.), Wellington Hospital, Wellington, New Zealand; Wellington Free Ambulance (A.H.S., M.G.M., M.C.H.), Wellington, New Zealand; and Department of Medicine (A.R.), University of Otago, Wellington, New Zealand.
Neurology. 2022 Nov 8;99(19):e2125-e2136. doi: 10.1212/WNL.0000000000201104. Epub 2022 Aug 31.
Stroke reperfusion therapy is time critical. Improving prehospital diagnostic accuracy including the likelihood of large vessel occlusion can aid with efficient and appropriate diversion decisions to optimize onset-to-treatment time. In this study, we investigated whether prehospital telestroke improves diagnostic accuracy when compared with paramedic assessments and assessed feasibility.
We conducted a pragmatic, community-based, cluster randomized controlled trial comparing the diagnostic accuracy of telestroke assessments inside the ambulance with a modified Los Angeles Motor Scale (PASTA score). The primary outcome was the accuracy of predicting reperfusion candidates; secondary outcomes were accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of either approach to identify IV thrombolysis (IVT) and endovascular thrombectomy (EVT) candidates and true stroke patients by study group. The accuracy of telestroke and PASTA assessments was compared against in-person assessment in the emergency department and with the final diagnosis/intervention for the patient. We also monitored for technical challenges.
We recruited 76 patients (35 telestroke and 41 PASTA) between August 2019 and September 2020. The mean age was 72.2 (±14.6) years. Telestroke was 100% (95% CI 90%-100%) and PASTA 70.7% (54.5%-83.9%) accurate in predicting reperfusion candidates compared with preimaging emergency department neurologist assessment ( < 0.001). When compared with actual reperfusion therapy administered, the predictive accuracy was 80% (63.1%-91.6%) and 60.1% (44.5%-75.8%) for telestroke and PASTA, respectively ( < 0.001). In predicting the administration of IVT, telestroke was 80% (63.1-91.6) and PASTA was 56.1% (39.8-71.5) accurate ( < 0.001). In predicting intervention with EVT, telestroke was 88.6% (73.3-96.8) and PASTA 56.1% (39.8-71.5) accurate ( = 0.005). The service model proved technically feasible and was acceptable to neurologists.
Prehospital telestroke assessment is feasible, accurate, and superior to the PASTA score in predicting acute reperfusion therapies, presenting an effective option to guide prehospital diversion decisions.
The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12619001678189).anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378655&isReview=true.
This study provides Class I evidence that intra-ambulance telestroke evaluation has a greater diagnostic accuracy compared with the PASTA score performed by paramedics in distinguishing hyperacute stroke patients who are candidates for reperfusion therapy.
卒中再灌注治疗时间紧迫。提高院前诊断准确率,包括大血管闭塞的可能性,有助于高效、合理地做出分流决策,以优化发病至治疗时间。本研究旨在探讨与急救人员评估相比,院前远程卒中评估是否能提高诊断准确性,并评估其可行性。
我们开展了一项基于社区的实用型、集群随机对照试验,比较了救护车内远程卒中评估与改良洛杉矶电机量表(PASTA 评分)的诊断准确性。主要结局是预测再灌注候选者的准确性;次要结局是通过研究组确定 IV 溶栓(IVT)和血管内血栓切除术(EVT)候选者和真正卒中患者的准确性、灵敏度、特异性、阳性预测值和阴性预测值。远程卒中和 PASTA 评估的准确性与急诊室的亲自评估以及患者的最终诊断/干预进行了比较。我们还监测了技术挑战。
2019 年 8 月至 2020 年 9 月,我们招募了 76 名患者(35 名远程卒中,41 名 PASTA)。平均年龄为 72.2(±14.6)岁。与急诊室的神经科医生预成像评估相比,远程卒中在预测再灌注候选者方面的准确率为 100%(95%CI 90%-100%),PASTA 为 70.7%(54.5%-83.9%)(<0.001)。与实际给予的再灌注治疗相比,远程卒中的预测准确率为 80%(63.1%-91.6%),PASTA 为 60.1%(44.5%-75.8%)(<0.001)。在预测 IVT 治疗方面,远程卒中的准确率为 80%(63.1-91.6),PASTA 为 56.1%(39.8-71.5)(<0.001)。在预测 EVT 干预方面,远程卒中的准确率为 88.6%(73.3-96.8),PASTA 为 56.1%(39.8-71.5)(=0.005)。该服务模式在技术上被证明是可行的,并且得到了神经科医生的认可。
院前远程卒中评估是可行的、准确的,并且在预测急性再灌注治疗方面优于 PASTA 评分,为指导院前分流决策提供了有效的选择。
该试验在澳大利亚和新西兰临床试验注册中心(ACTRN12619001678189)进行了注册。anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378655&isReview=true.
本研究提供了 I 级证据,表明与急救人员进行的 PASTA 评分相比,救护车内的远程卒中评估在区分适合再灌注治疗的超急性卒中患者方面具有更高的诊断准确性。